First-in-human Study of DS-1062a for Advanced Solid Tumors (TROPION-PanTumor01)

NCT03401385 · clinicaltrials.gov ↗

PHASE1

Phase

ACTIVE_NOT_RECRUITING

Status

890

Enrollment

INDUSTRY

Sponsor class

Conditions

Hormone Receptor Positive Breast Cancer
Triple Negative Breast Cancer
Non-small Cell Lung Cancer

Interventions

DRUG: Datopotamab Deruxtecan (Dato-DXd)
DRUG: Steroid Containing Mouthwash
OTHER: Non-Steroid Containing Mouthwash

Sponsor

Daiichi Sankyo Co., Ltd.

Collaborators

[object Object]
[object Object]